학술논문
Risk-adjusted hazard analysis of survival after pulmonary metastasectomy for uterine malignancies in 319 casesCentral MessagePerspective
Document Type
article
Author
Yuya Nobori, MD; Masaki Anraku, MD; Yoshikane Yamauchi, MD; Mingyon Mun, MD; Ichiro Yoshino, MD; Jun Nakajima, MD, PhD; Norihiko Ikeda, MD; Haruhisa Matsuguma, MD; Takekazu Iwata, MD; Yasushi Shintani, MD; Mitsuo Nakayama, MD; Takahiko Oyama, MD; Masayuki Chida, MD; Hiroaki Kuroda, MD; Hiroshi Hashimoto, MD; Yoko Azuma, MD; Kazuhito Funai, MD; Makoto Endoh, MD; Yukari Uemura, PhD; Masafumi Kawamura, MD
Source
JTCVS Open, Vol 13, Iss , Pp 411-422 (2023)
Subject
Language
English
ISSN
2666-2736
Abstract
Objective: There is little evidence of the outcome of pulmonary metastasectomy for uterine tumors when comparing different histologies. This study aimed to delineate the primary histology that leads to more favorable outcomes after pulmonary metastasectomy. Methods: The database of the Metastatic Lung Tumor Study Group of Japan for 1984 to 2016 was used to analyze the outcomes of patients with gynecologic malignancies who underwent pulmonary metastasectomy. Prognostic factors and long-term outcomes were compared according to the histology of the primary uterine tumors, specifically adenocarcinoma, squamous cell carcinoma, and sarcoma. The adjusted hazard risks according to disease-free intervals (DFIs) and the number and maximum size of resected tumors were also analyzed to delineate the pattern of risk trends. Results: A total of 319 patients were included in the analysis (122 with adenocarcinomas, 113 with squamous cell carcinomas, 46 with sarcomas, and 38 with other types). The 5-year survival rate was 66.5% for the entire cohort, 71.6% for the patients with adenocarcinoma, 61.3% for those with squamous cell carcinoma, and 55.4% for those with sarcoma. Multivariate analyses identified the positive prognostic factors as DFI ≥12 months in adenocarcinoma and sarcoma and the primary site (corpus) of uterine tumors in adenocarcinoma. The nonlinear adjusted hazard risks indicated that a shorter DFI was associated with an elevated risk of death in patients with adenocarcinoma and sarcoma. Conclusions: The survival outcome after pulmonary metastasectomy varies according to primary tumor histology, and the prognostic factors differ among histologic subtypes. Surgical indications should be determined based on the prognostic factors for each histology.